HBM HOLDINGS-B(02142),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02142 HBM HOLDINGS-B

Market Closed 02-27 16:08:20

12.150

+0.270

+2.27%

High12.180	Low11.700	Vol1.90M
Open11.790	D1 Closing11.880	Amplitude4.04%
Mkt Cap10.57B	Tradable Cap10.57B	Total Shares870.00M
T/O22.74M	T/O Rate0.22%	Tradable Shares870.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02142","market":"HK","secType":"STK","nameCN":"HBM HOLDINGS-B","latestPrice":12.15,"timestamp":1772179700003,"preClose":11.88,"halted":0,"volume":1895251,"delay":0,"changeRate":0.02272727272727269,"floatShares":869999999,"shares":869999999,"eps":0.003616,"marketStatus":"Market Closed","change":0.27,"latestTime":"02-27 16:08:20","open":11.79,"high":12.18,"low":11.7,"amount":22740120,"amplitude":0.040404,"askPrice":12.16,"askSize":6000,"bidPrice":12.15,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":0.661,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1772415000000},"marketStatusCode":7,"adr":0,"listingDate":1607529600000,"exchange":"SEHK","adjPreClose":11.88,"openAndCloseTimeList":[[1772155800000,1772164800000],[1772168400000,1772179200000]],"volumeRatio":0.5601713075565717,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02142/tweets","defaultTab":"tweets","newsList":[{"id":"1192835304","title":"Zhongtai Securities Reiterates \"Buy\" on HBM HOLDINGS-B (02142) Following Heavy-Chain Antibody HBM4003 Out-Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1192835304","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192835304?lang=en_us&edition=fundamental","pubTime":"2026-02-27 09:48","pubTimestamp":1772156902,"startTime":"0","endTime":"0","summary":"Zhongtai Securities has reaffirmed its \"Buy\" rating on HBM HOLDINGS-B (02142). The rating is based on the incremental revenue expected from upfront, near-term payments, and risk-adjusted milestone...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0276","BK1574","BK1583","BK1161","02142","600918"],"gpt_icon":0},{"id":"2613046793","title":"HBM Holdings (SEHK:2142) Valuation After Solstice Oncology Partnership On HBM4003 Rights Outside Greater China","url":"https://stock-news.laohu8.com/highlight/detail?id=2613046793","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613046793?lang=en_us&edition=fundamental","pubTime":"2026-02-24 15:32","pubTimestamp":1771918325,"startTime":"0","endTime":"0","summary":"HBM Holdings (SEHK:2142) shares have been in focus after the company signed an exclusive license and equity partnership with Solstice Oncology, centered on its clinical asset HBM4003 outside Greater China.\nSee our latest analysis for HBM Holdings.\nThe Solstice agreement arrives as momentum in HBM Holdings' shares has picked up again, with a 1 day share price return of 4.41% and 7 day share price return of 8.12%, while the 1 year total shareholder return of 123.82% and 3 year total shareholder...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-valuation-after-solstice-oncology-part","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-valuation-after-solstice-oncology-part","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","DCF","BK4168","BK1161","02142","HBM","BK1583"],"gpt_icon":0},{"id":"2613440208","title":"BUZZ-HK-listed HBM jumps on licensing deal with Solstice on oncology drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2613440208","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613440208?lang=en_us&edition=fundamental","pubTime":"2026-02-23 10:22","pubTimestamp":1771813359,"startTime":"0","endTime":"0","summary":"BUZZ-HK-listed HBM jumps on licensing deal with Solstice on oncology drug ** Shares of HBM Holdings 2142.HK jump 9.3% to HK$13.38, their highest level since January 20, and on course for a third straight session of gains** Stock of the Chinese immuno-oncology and immunology diseases therapeutics developer on track for biggest one-day pct gain since August 29** HBM says it has agreed to grant Solstice Oncology - a clinical-stage biotechnology firm set up by venture capital investors, an exclusive license to develop and commercialise a clinical-stage portfolio asset for tumors treatment HBM4003  outside Greater China  ** HBM is eligible to receive upfront consideration valued at $105 million, comprising an upfront cash payment of $50 million, a near-term cash payment of $5 million, and over $50 million of equity interest in Solstice Oncology to be issued and allotted to the company** HBM is also eligible to receive regulatory and commercial milestone payments of up to $1.1 billion on the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nL1N3ZJ014:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1583","BK1574","02142"],"gpt_icon":0},{"id":"1158828817","title":"HBM HOLDINGS-B Shares Surge Over 8% in Morning Session on Major Global Licensing Deal for Next-Generation Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=1158828817","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158828817?lang=en_us&edition=fundamental","pubTime":"2026-02-23 09:50","pubTimestamp":1771811417,"startTime":"0","endTime":"0","summary":"HBM HOLDINGS-B (02142) saw its shares rise more than 8% during the morning trading session. At the time of writing, the stock was up 7.92%, trading at HK$13.21 with a turnover of HK$217.947 million....","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK1574","VT","VXUS","BK1161","BK1583","BK4588","02142"],"gpt_icon":0},{"id":"1187325623","title":"HBM Holdings (02142) Enters Exclusive Agreement with Solstice Oncology for HBM4003","url":"https://stock-news.laohu8.com/highlight/detail?id=1187325623","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187325623?lang=en_us&edition=fundamental","pubTime":"2026-02-23 08:23","pubTimestamp":1771806229,"startTime":"0","endTime":"0","summary":"HBM Holdings (02142) and Solstice Oncology have entered an exclusive license and equity partnership involving HBM4003 outside Greater China. Under the agreement, total upfront consideration exceeds...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142"],"gpt_icon":0},{"id":"1142228049","title":"HBM HOLDINGS-B Enters Exclusive Licensing and Equity Partnership for HBM4003 with Solstice Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=1142228049","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142228049?lang=en_us&edition=fundamental","pubTime":"2026-02-23 08:16","pubTimestamp":1771805818,"startTime":"0","endTime":"0","summary":"HBM HOLDINGS-B (02142) has announced the signing of an exclusive licensing agreement and an equity cooperation agreement with Solstice Oncology, a clinical-stage biotechnology company established by...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2613724152","title":"HBM Holdings inks licensing and equity partnership deal with Solstice Oncology for HBM4003","url":"https://stock-news.laohu8.com/highlight/detail?id=2613724152","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613724152?lang=en_us&edition=fundamental","pubTime":"2026-02-23 08:00","pubTimestamp":1771804849,"startTime":"0","endTime":"0","summary":"HBM Holdings Ltd. has entered into an exclusive license agreement and equity partnership with Solstice Oncology to develop and commercialize its clinical-stage asset HBM4003 outside Greater China. HBM said it is eligible to receive upfront consideration valued at over US$105 million, including US$55 million in cash and more than US$50 million in Solstice equity, plus up to about US$1.1 billion in milestones and tiered royalties on net sales outside Greater China.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HBM Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 23, 2026, and is solely responsible for the informat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL7nBBtv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","BK1161","02142"],"gpt_icon":0},{"id":"2613724962","title":"Hbm Holdings - License Agreement and Equity Partnership Agreement With Solstice Oncology for Hbm4003","url":"https://stock-news.laohu8.com/highlight/detail?id=2613724962","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613724962?lang=en_us&edition=fundamental","pubTime":"2026-02-23 08:00","pubTimestamp":1771804840,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nFWN3ZG0TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02142","BK1583","BK1574"],"gpt_icon":0},{"id":"2613272499","title":"Hbm Holdings -  Co to GET Upfront Consideration Valued at Over US$105 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2613272499","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613272499?lang=en_us&edition=fundamental","pubTime":"2026-02-23 08:00","pubTimestamp":1771804840,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nFWN3ZG0TW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1574","02142","BK1583"],"gpt_icon":0},{"id":"2613272479","title":"Hbm Holdings - Eligible to Receive Additional Development, Regulatory and Commercial Milestone Payments of up to US$1.1 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2613272479","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613272479?lang=en_us&edition=fundamental","pubTime":"2026-02-23 08:00","pubTimestamp":1771804840,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nFWN3ZG0TW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02142","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"1158032607","title":"HBM Holdings (02142) Announces Clarification on Share Option Figures","url":"https://stock-news.laohu8.com/highlight/detail?id=1158032607","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158032607?lang=en_us&edition=fundamental","pubTime":"2026-02-16 16:21","pubTimestamp":1771230112,"startTime":"0","endTime":"0","summary":"HBM Holdings (02142) released a clarification regarding previously announced share option data spanning 12 January 2024 to 1 January 2026, as well as figures disclosed in its 2022, 2023, and 2024...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142"],"gpt_icon":0},{"id":"1173253953","title":"HBM Holdings Limited (02142) Announces Monthly Return for January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1173253953","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173253953?lang=en_us&edition=fundamental","pubTime":"2026-02-06 08:04","pubTimestamp":1770336255,"startTime":"0","endTime":"0","summary":"HBM Holdings Limited (02142) submitted a monthly return for the period ended 31 January 2026, disclosing that its authorised share capital remained at 20,000,000,000 ordinary shares with a par value...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142"],"gpt_icon":0},{"id":"1103445591","title":"HBM HOLDINGS-B (02142) Jumps Over 3% on Profit Alert, Forecasts Annual Profit Up to ~$95M as Recurring Revenue Grows","url":"https://stock-news.laohu8.com/highlight/detail?id=1103445591","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103445591?lang=en_us&edition=fundamental","pubTime":"2026-02-04 09:30","pubTimestamp":1770168626,"startTime":"0","endTime":"0","summary":"HBM HOLDINGS-B (02142) opened more than 3% higher following a positive profit alert. At the time of writing, the stock was up 3.44% to HK$11.44, with a turnover of HK$480,500. On February 4, HBM...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK1583","BK1574","VT","BK4588","BK1161","BK4585","02142"],"gpt_icon":0},{"id":"2608814933","title":"Press Release: Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2608814933","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608814933?lang=en_us&edition=fundamental","pubTime":"2026-02-04 08:01","pubTimestamp":1770163260,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Feb. 3, 2026 /PRNewswire/ -- Harbour BioMed , a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced a positive profit alert for the year ended December 31, 2025.Based on a preliminary review of the Company's unaudited management accounts for the Reporting Period, total profit is expected to range between US$88 million  and US$95 million , as compared to a profit of approximately US$2.7 million for the year ended December 31, 2024. Total adjusted profit([1]) is expected to range between US$91 million  and US$98 million .The anticipated increase in profit is primarily attributable to:. -- Continued growth of recurring revenue stream of the Company, such as the. platform-based research collaboration with AstraZeneca and Bristol Myers. -- Accelerated expansion of global partner network, as the revenue generated. from out-licensing and colla","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02142","BK4585","BK1574","R","TM","BK4555","BK4604","BK1161","BK4232","BK4022","BK4588","03160","BK4099"],"gpt_icon":0},{"id":"2608381480","title":"HBM Holdings Expects 2025 Profit to Surge to Up to US$95 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2608381480","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608381480?lang=en_us&edition=fundamental","pubTime":"2026-02-04 08:00","pubTimestamp":1770163256,"startTime":"0","endTime":"0","summary":"HBM Holdings Ltd. has announced a significant increase in its expected profit for the year ended 31 December 2025. Based on preliminary unaudited management accounts, the company anticipates its profit to be in the range of approximately US$88 million to US$95 million, a sharp rise compared to a profit of about US$2.7 million recorded for the previous year. Additionally, total adjusted profit is projected to be between US$91 million and US$98 million, highlighting a substantial improvement in the company’s business performance for the period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HBM Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong S","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL15jN4F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02142","BK1574","BK1583"],"gpt_icon":0},{"id":"2607700228","title":"AstraZeneca sets out $15 billion China investment during Starmer visit","url":"https://stock-news.laohu8.com/highlight/detail?id=2607700228","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607700228?lang=en_us&edition=fundamental","pubTime":"2026-01-29 18:03","pubTimestamp":1769681014,"startTime":"0","endTime":"0","summary":"UPDATE 2-AstraZeneca sets out $15 billion China investment during Starmer visitAdds details on investment goals, new paragraphs 3 onwardsInvestment is AstraZeneca's largest to date in ChinaWill enhanc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nL8N3YU11W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1481599808.USD","LU1551013342.USD","LU1496350171.SGD","LU1914381329.SGD","LU0432979614.USD","IE00B3S45H60.SGD","IE00BJTD4N35.SGD","LU2023250843.SGD","AZN.UK","LU2552382058.USD","LU0208291251.USD","02142","LU0943347566.SGD","LU1267930813.SGD","LU2236285917.USD","LU2381873111.SGD","LU2133065610.SGD","LU2552382132.HKD","BK4207","LU2552382215.SGD","LU1145028129.USD","IE00BFTCPJ56.SGD","LU1301847155.USD","LU2237443465.HKD","LU2456880835.USD","03165","LU1019632923.USD","IE00BJLML261.HKD","LU2505996509.AUD","LU2112291526.USD","LU0158827948.USD","LU0234572021.USD","LU0942090050.USD","IE000M9KFDE8.USD","LU1880407132.USD","LU0920783379.SGD","LU0320765646.SGD","LU0345769128.USD","LU1153585028.USD","LU1668664300.SGD","LU0820561818.USD","LU1078025761.USD","LU1496350502.SGD","LU0029864427.USD","LU0708994859.HKD","LU0310800379.SGD","LU0882574055.USD","LU0827474353.SGD","LU0211331839.USD","LU2505996681.GBP"],"gpt_icon":0},{"id":"2607882775","title":"HBM Holdings Plans Up to HK$300 Million Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2607882775","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607882775?lang=en_us&edition=fundamental","pubTime":"2026-01-29 10:36","pubTimestamp":1769654219,"startTime":"0","endTime":"0","summary":"HBM Holdings (HKG:2142) plans to repurchase up to HK$300 million of its shares on the open market under its general mandate, according to a Thursday Hong Kong bourse filing.The repurchased shares may be cancelled, held in treasury, sold, or transferred, at the board's discretion, the filing said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK1574","BK1583","02142"],"gpt_icon":0},{"id":"2607720130","title":"BRIEF-HBM Holdings To Repurchase Shares Up To HK$300 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2607720130","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607720130?lang=en_us&edition=fundamental","pubTime":"2026-01-29 09:29","pubTimestamp":1769650156,"startTime":"0","endTime":"0","summary":"BRIEF-HBM Holdings To Repurchase Shares Up To HK$300 MillionJan 29 (Reuters) - Hbm Holdings Ltd 2142.HK:TO REPURCHASE SHARES UP TO HK$300 MILLIONFurther company coverage: 2142.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YT178:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","02142","BK1583"],"gpt_icon":0},{"id":"1160691310","title":"HBM HOLDINGS-B (02142) Plans to Repurchase Up to HK$300 Million in Company Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1160691310","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160691310?lang=en_us&edition=fundamental","pubTime":"2026-01-29 08:09","pubTimestamp":1769645381,"startTime":"0","endTime":"0","summary":"HBM HOLDINGS-B (02142) announced that, pursuant to the general mandate for share repurchases approved by shareholders at the Annual General Meeting held on June 11, 2025, and any subsequent general...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02142","BK1574","BK1583"],"gpt_icon":0},{"id":"2607724314","title":"Hbm Holdings - to Repurchase Shares up to HK$300 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2607724314","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607724314?lang=en_us&edition=fundamental","pubTime":"2026-01-29 08:00","pubTimestamp":1769644838,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YT178:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1583","BK1161","02142"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":0.0202},{"period":"3month","weight":-0.0987},{"period":"6month","weight":-0.1746},{"period":"1year","weight":1.1735},{"period":"ytd","weight":-0.0008}],"compareEarnings":[{"period":"1week","weight":0.0082},{"period":"1month","weight":-0.043},{"period":"3month","weight":0.0298},{"period":"6month","weight":0.0619},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.039}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Hbm Holdings Ltd is an investment holding company primarily engaged in the business of developing innovative therapeutics in the fields of immuno-oncology and immunology diseases. The Company’s products primarily include BATOCLIMAB (HBM9161), HBM9378, HBM7020, TCE Program, PORUSTOBART (HBM4003), HBM7022 and others. The products are primarily used to treat generalized myasthenia gravis (gMG), chronic obstructive pulmonary disease (COPD), asthma, autoimmune diseases, melanoma, colorectal carcinoma (CRC) and solid tumors. The Company provides next-generation antibody and biotherapeutic solutions through proprietary antibody technology platforms including Harbour Mice, HBICE, HBICA and single B cell cloning platform.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.083377},{"month":2,"riseRate":0.333333,"avgChangeRate":0.000026},{"month":3,"riseRate":0.4,"avgChangeRate":0.046232},{"month":4,"riseRate":0.4,"avgChangeRate":0.013317},{"month":5,"riseRate":0.6,"avgChangeRate":0.040454},{"month":6,"riseRate":0.2,"avgChangeRate":-0.066065},{"month":7,"riseRate":0.4,"avgChangeRate":0.030357},{"month":8,"riseRate":0.2,"avgChangeRate":0.005624},{"month":9,"riseRate":0.4,"avgChangeRate":-0.065735},{"month":10,"riseRate":0,"avgChangeRate":-0.180686},{"month":11,"riseRate":0.8,"avgChangeRate":0.25789},{"month":12,"riseRate":0.6,"avgChangeRate":0.266929}],"exchange":"SEHK","name":"HBM HOLDINGS-B","nameEN":"HBM HOLDINGS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HBM HOLDINGS-B(02142),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HBM HOLDINGS-B(02142) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HBM HOLDINGS-B,02142,HBM HOLDINGS-B股票,HBM HOLDINGS-B股票老虎,HBM HOLDINGS-B股票老虎国际,HBM HOLDINGS-B行情,HBM HOLDINGS-B股票行情,HBM HOLDINGS-B股价,HBM HOLDINGS-B股市,HBM HOLDINGS-B股票价格,HBM HOLDINGS-B股票交易,HBM HOLDINGS-B股票购买,HBM HOLDINGS-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HBM HOLDINGS-B(02142),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HBM HOLDINGS-B(02142) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}